The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities
Open accessAbstract
Continuous glucose monitoring (CGM) provides information unattainable by intermittent capillary blood glucose, including instantaneous real-time display of glucose level and rate of change of glucose, alerts and alarms for actual or impending hypo- and hyperglycemia, "24/7" coverage, and the ability to characterize glycemic variability. Progressively more accurate and precise, reasonably unobtrusive, small, comfortable, user-friendly devices connect to the Internet to share information and are sine qua non for a closed-loop artificial pancreas. CGM can inform, educate, motivate, and alert people with diabetes. CGM is medically indicated for patients with frequent, severe, or nocturnal hypoglycemia, especially in the presence of hypoglycemia unawareness. Surprisingly, despite tremendous advances, utilization of CGM has remained fairly limited to date. Barriers to use have included the following: (1) lack of Food and Drug Administration approval, to date, for insulin dosing ("nonadjuvant use") in the United States and for use in hospital and intensive care unit settings; (2) cost and variable reimbursement; (3) need for recalibrations; (4) periodic replacement of sensors; (5) day-to-day variability in glycemic patterns, which can limit the predictability of findings based on retrospective, masked "professional" use; (6) time, implicit costs, and inconvenience for uploading of data for retrospective analysis; (7) lack of fair and reasonable reimbursement for physician time; (8) inexperience and lack of training of physicians and other healthcare professionals regarding interpretation of CGM results; (9) lack of standardization of software methods for analysis of CGM data; and (10) need for professional medical organizations to develop and disseminate additional clinical practice guidelines regarding the role of CGM. Ongoing advances in technology and clinical research have addressed several of these barriers. Use of CGM in conjunction with an insulin pump with automated suspension of insulin infusion in response to actual observed or predicted hypoglycemia, as well as progressive refinement of closed-loop systems, is expected to dramatically enhance the clinical utility and utilization of CGM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miller, K. M., Foster, N. C., Beck, R. W., Bergenstal, R. M., DuBose, S. N., DiMeglio, L. A., Maahs, D. M., & Tamborlane, W. V. (2015) · Diabetes Care · doi:10.2337/dc15-0078 · Cited by 1,254
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685 · cited 2×
“One can expect that user acceptance will continue to improve as sensor lifetime increases and ease of sensor insertion improves.(3) Calibration Calibration using capillary blood glucose meters and reagent strips involves cost, discomfort, and inconvenience, increases the number of devices and complexity, and may add p…”
BackgroundMethodOutpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes
Russell, S. J., El-Khatib, F. H., Sinha, M., Magyar, K. L., McKeon, K., Goergen, L. G., Balliro, C., Hillard, M. A., Nathan, D. M., & Damiano, E. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314474 · Cited by 602
Home Use of an Artificial Beta Cell in Type 1 Diabetes
Thabit, H., Tauschmann, M., Allen, J. M., Leelarathna, L., Hartnell, S., Wilinska, M. E., Acerini, C. L., Dellweg, S., Benesch, C., Heinemann, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509351 · Cited by 450
The effect of continuous glucose monitoring in well-controlled type 1 diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0108 · Cited by 399
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A. J., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0303 · Cited by 318
Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1502 · Cited by 313
Bergenstal, R. M., Ahmann, A. J., Bailey, T., Beck, R. W., Bissen, J., Buckingham, B., Deeb, L., Dolin, R. H., Garg, S. K., Goland, R., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0051 · Cited by 307
Performance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home Use
Gross, T. M., Bode, B. W., Einhorn, D., Kayne, D. M., Reed, J. H., White, N. H., & Mastrototaro, J. J. (2000) · Diabetes Technology & Therapeutics · doi:10.1089/152091500316737 · Cited by 303
Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose Monitoring
Kovatchev, B. P., Patek, S. D., Ortiz, E. A., & Breton, M. D. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0272 · Cited by 234
Cited by
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
“obstacles, clinician inexperience in data interpretation and lack of standardization software for visualization of CGM data have also played a role (73).”
Self-citationWearable biosensors for healthcare monitoring
Kim, J., Campbell, A. S., de Ávila, B. E.-F., & Wang, J. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0045-y · Cited by 3,373
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Electrochemical glucose sensors in diabetes management: an updated review (2010–2020)
Teymourian, H., Barfidokht, A., & Wang, J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00304b · Cited by 881
Wearable non-invasive epidermal glucose sensors: A review
Kim, J., Campbell, A. S., & Wang, J. (2018) · Talanta · doi:10.1016/j.talanta.2017.08.077 · Cited by 586
Yetisen, A. K., Martinez‐Hurtado, J. L., Ünal, B., Khademhosseini, A., & Butt, H. (2018) · Advanced Materials · doi:10.1002/adma.201706910 · Cited by 569
Remote patient monitoring: a comprehensive study
Malasinghe, L. P., Ramzan, N., & Dahal, K. (2019) · Journal of Ambient Intelligence and Humanized Computing · doi:10.1007/s12652-017-0598-x · Cited by 534
Wearable Electrochemical Glucose Sensors in Diabetes Management: A Comprehensive Review
Saha, T., Del Caño, R., Mahato, K., De la Paz, E., Chen, C., Ding, S., Yin, L., & Wang, J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00078 · Cited by 442
Wearable Contact Lens Biosensors for Continuous Glucose Monitoring Using Smartphones
Elsherif, M., Hassan, M. U., Yetisen, A. K., & Butt, H. (2018) · ACS Nano · doi:10.1021/acsnano.8b00829 · Cited by 371
Opportunities and challenges in the diagnostic utility of dermal interstitial fluid
Friedel, M., Thompson, I. A. P., Kasting, G., Polsky, R., Cunningham, D., Soh, H. T., & Heikenfeld, J. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00998-9 · Cited by 360
Glucose‐Sensitive Hydrogel Optical Fibers Functionalized with Phenylboronic Acid
Yetisen, A. K., Jiang, N., Fallahi, A., Montelongo, Y., Ruiz‐Esparza, G. U., Tamayol, A., Zhang, Y. S., Mahmood, I., Yang, S., Kim, K. S., et al. (2017) · Advanced Materials · doi:10.1002/adma.201606380 · Cited by 311
Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels
Bergenstal, R. M., Gal, R. L., Connor, C. G., Gubitosi-Klug, R., Kruger, D., Olson, B. A., Willi, S. M., Aleppo, G., Weinstock, R. S., Wood, J., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2596 · Cited by 306
Zhang, D., Chen, Q., Shi, C., Chen, M., Ma, K., Wan, J., & Liu, R. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202007226 · Cited by 303
Glucose‐Responsive Insulin and Delivery Systems: Innovation and Translation
Wang, J., Wang, Z., Yu, J., Kahkoska, A. R., Buse, J. B., & Gu, Z. (2020) · Advanced Materials · doi:10.1002/adma.201902004 · Cited by 295
Electrochemical Glucose Sensing: Is There Still Room for Improvement?
Witkowska Nery, E., Kundys, M., Jeleń, P. S., & Jönsson-Niedziółka, M. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03151 · Cited by 292
Deep Learning for Diabetes: A Systematic Review
Zhu, T., Li, K., Herrero, P., & Georgiou, P. (2021) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.3040225 · Cited by 264
Charleer, S., De Block, C., Van Huffel, L., Broos, B., Fieuws, S., Nobels, F., Mathieu, C., & Gillard, P. (2020) · Diabetes Care · doi:10.2337/dc19-1610 · Cited by 261
Dunn, T. C., Xu, Y., Hayter, G., & Ajjan, R. A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.12.015 · Cited by 239
Xie, X., Doloff, J. C., Yesilyurt, V., Sadraei, A., McGarrigle, J. J., Omami, M., Veiseh, O., Farah, S., Isa, D., Ghani, S., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0273-3 · Cited by 235
Coming of age: the artificial pancreas for type 1 diabetes
Thabit, H., & Hovorka, R. (2016) · Diabetologia · doi:10.1007/s00125-016-4022-4 · Cited by 223
Glycemic variability: how to measure and its clinical implication for type 2 diabetes
Umpierrez, G. E., & P. Kovatchev, B. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.09.010 · Cited by 148
Continuous Glucose Monitoring: Review of an Innovation in Diabetes Management
Mian, Z., Hermayer, K. L., & Jenkins, A. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.07.003 · Cited by 139
Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations
Petrie, J. R., Peters, A. L., Bergenstal, R. M., Holl, R. W., Fleming, G. A., & Heinemann, L. (2017) · Diabetes Care · doi:10.2337/dci17-0043 · Cited by 135
Šoupal, J., Petruželková, L., Flekač, M., Pelcl, T., Matoulek, M., Daňková, M., Škrha, J., Svačina, Š., & Prázný, M. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0171 · Cited by 126
Gingras, V., Taleb, N., Roy‐Fleming, A., Legault, L., & Rabasa‐Lhoret, R. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13052 · Cited by 113
Elbalshy, M., Haszard, J., Smith, H., Kuroko, S., Galland, B., Oliver, N., Shah, V., de Bock, M. I., & Wheeler, B. J. (2022) · Diabetic Medicine · doi:10.1111/dme.14854 · Cited by 104
Continuous glucose monitoring: Current use in diabetes management and possible future applications
Vettoretti, M., Cappon, G., Acciaroli, G., Facchinetti, A., & Sparacino, G. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818774078 · Cited by 96
Yoo, J. H., Kim, G., Lee, H. J., Sim, K. H., Jin, S.-M., & Kim, J. H. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109209 · Cited by 58
Device and method for noninvasive glucose assessment
Segman, Y. (. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818763457 · Cited by 55
A Review of Research Progress on Glycemic Variability and Gestational Diabetes
Yu, W., Wu, N., Li, L., OuYang, H., Qian, M., & Shen, H. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s261486 · Cited by 44
Applications of Self-Supervised Learning to Biomedical Signals: A Survey
Pup, F. D., & Atzori, M. (2023) · IEEE Access · doi:10.1109/access.2023.3344531 · Cited by 43
The History, Evolution and Future of Continuous Glucose Monitoring (CGM)
Bender, C., Vestergaard, P., & Cichosz, S. L. (2025) · Diabetology · doi:10.3390/diabetology6030017 · Cited by 43
Continuous glucose monitoring for hypoglycaemia in children: perspectives in 2020
Worth, C., Dunne, M., Ghosh, A., Harper, S., & Banerjee, I. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13029 · Cited by 37
“The Advanced Technologies and Treatments for Diabetes (ATTD) Congress devised a consensus recommendation for CGM data utilization to try to aim interpretation and standardize use.77 The development of an auto- mated interpretation of CGM data specific to those with hypoglycaemia disorders would go a long way to reduci…”
BackgroundInfluentialValenzano, M., Cibrario Bertolotti, I., Valenzano, A., & Grassi, G. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001045 · Cited by 34
Smith, K. E., Mason, T. B., Juarascio, A., Schaefer, L. M., Crosby, R. D., Engel, S. G., & Wonderlich, S. A. (2019) · International Journal of Eating Disorders · doi:10.1002/eat.23124 · Cited by 34
“Notably, research outside of EDs has seen tremendous growth in the use of ambulatory biosensors to assess a range of other physiological indices including cortisol, electrodermal activity, and glucose (e.g., Kleckner et al., 2018; Rodbard, 2016; Smyth, Zawadzki, Juth, & Sciamanna, 2017).”
BackgroundSharing patient-generated data with healthcare providers: findings from a 2019 national survey
Turner, K., Jo, A., Wei, G., Tabriz, A. A., Clary, A., & Jim, H. S. L. (2021) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa272 · Cited by 33
Zhang, W., Liu, Y., Sun, B., Shen, Y., Li, M., Peng, L., Duan, H., Su, X., Lu, S., Tian, X., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-03480-9 · Cited by 32
Distinct patterns of daily glucose variability by pubertal status in youth with type 1 diabetes
Zhu, J., Volkening, L. K., & Laffel, L. M. (2020) · Diabetes Care · doi:10.2337/dc19-0083 · Cited by 30
Use of Diabetes Technology in Children
Desrochers, H. R., Schultz, A. T., & Laffel, L. M. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.11.001 · Cited by 29
Kumar, S., Soldatos, G., Ranasinha, S., Teede, H., & Pallin, M. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2022.07.013 · Cited by 24
Camerlingo, N., Vettoretti, M., Del Favero, S., Cappon, G., Sparacino, G., & Facchinetti, A. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0139 · Cited by 22
“6,7 The real-time availability of CGM data allows predicting in the short-term (e.g., 20–30 min ahead of time) incoming hypoglycemic events, 8–16 with the possibility to suggest preventive carbohydrate consumption.”
Time Savings Using a Standardized Glucose Reporting System and Ambulatory Glucose Profile
Mullen, D. M., Bergenstal, R., Criego, A., Arnold, K. C., Goland, R., & Richter, S. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817740592 · Cited by 22
Hirsch, I. B., & Verderese, C. A. (2017) · Endocrine Practice · doi:10.4158/ep171962.ra · Cited by 22
Beyond A1C: exploring continuous glucose monitoring metrics in managing diabetes
Friedman, J. G., Coyne, K., Aleppo, G., & Szmuilowicz, E. D. (2023) · Endocrine Connections · doi:10.1530/ec-23-0085 · Cited by 22
Wang, J., Wang, Z., Yu, J., Zhang, Y., Zeng, Y., & Gu, Z. (2019) · Biomaterials Science · doi:10.1039/c9bm01283d · Cited by 21
Kasthuri, S., Poongothai, S., Anjana, R. M., Selvakumar, J., Muthukumar, S., Kayalvizhi, S., Tariq, S., Honey, E., Gupta, P. K., Venkatesan, U., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0484 · Cited by 13
Challenges and Potential of Using Digital Biomarkers in Healthcare and Clinical Trials
Lieberwirth, J. K., Mittermaier, M., & Stern, A. D. (2026) · Communications Medicine · doi:10.1038/s43856-026-01450-8 · Cited by 13
Rubelj, K. (2021) · Acta Clinica Croatica · doi:10.20471/acc.2021.60.04.07 · Cited by 13
Harris, S., Cimino, S., Nguyen, Y., Szafranski, K., & Poon, Y. (2025) · Diabetes Therapy · doi:10.1007/s13300-024-01677-5 · Cited by 12
Albanese-O’Neill, A. (2023) · Diabetes Spectrum · doi:10.2337/dsi23-0006 · Cited by 9
Al Hayek, A. A., & Al Dawish, M. A. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02508-y · Cited by 9
Burks, J. H., Joe, L., Kanjaria, K., Monsivais, C., O'laughlin, K., & Smarr, B. L. (2025) · PLOS Digital Health · doi:10.1371/journal.pdig.0000815 · Cited by 5
Ratzki-Leewing, A., Harris, S. B., Rabasa-Lhoret, R., & Poon, Y. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0609 · Cited by 3
Metadata
- Authors
- Rodbard, D.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2016-02
- Volume
- 18
- Issue
- S2
- Pages
- S2-3-S2-13
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2278129565
- Cited by
- 737
- References
- 50
- FWCI
- 70.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.